跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
AZACITIDINE FOR INJECTION - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
AZACITIDINE FOR INJECTION
Authorized
STANDARD
AZACITIDINE FOR INJECTION
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
fe875fb27ac10454
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
fe875fb27ac10454
Drug Approval Canada Name
AZACITIDINE FOR INJECTION
Product Name
AZACITIDINE FOR INJECTION
Status
Marketed
Status Date
2023-04-17
Original Market Date
2023-04-17
Din
02529599
Drug Class
Human
Dosage Form
Powder For Suspension
Route Of Administration
Subcutaneous
Schedule
Prescription
Ahfs
10:00.00
Atc Original
L01BC07 AZACITIDINE
Atc Name
l 01 bc 07
Aig Number
0152665001
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
AZACITIDINE
100 MG / VIAL
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
fe875fb27ac10454
Type
Standard
Back to Health Canada Approvals